RecruitingPhase 4NCT06690307

Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy

The Efficacy and Safety of Oxycodone in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy


Sponsor

Affiliated Hospital of Nantong University

Enrollment

64 participants

Start Date

Dec 3, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study is designed to evaluate the efficacy and safety of hydrocodone in patient-controlled intravenous analgesia (PCIA) during gynecological laparoscopy, thus to explore suitable PCIA scheme to optimize postoperative pain management for patients undergoing gynecological laparoscopic surgeries.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called patient controlled intravenous analgesia(PCIA) and a procedure called patient controlled intravenous analgesia(PCIA) for people with laparoscopic hysterectomy. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREpatient controlled intravenous analgesia(PCIA)

Patients will receive sulfentanil for PCIA.

PROCEDUREpatient controlled intravenous analgesia(PCIA)

Patients will receive oxycodone for PCIA.


Locations(1)

Affiliated hospital of Nantong University

Nantong, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06690307


Related Trials